NCT07176247View on ClinicalTrials.gov

Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Critical CareInfectionAntibiotic ResistanceInfectious Diseases
Interventions
DRUG

Aztreonam-Avibactam

Antibiotic therapy with Aztreonam-Avibactam

Trial Locations (1)

Unknown

French Society of Intensive Care (SRLF), Paris

All Listed Sponsors
collaborator

SPILF

UNKNOWN

lead

French Society for Intensive Care

OTHER